Q0510 – Pharmacy supply fee for initial immunosuppressive drug(s), first month following transplant
HCPCS Level II code · Q codes: Temporary Codes
HCPCS codeQ0510
- Long description
- Pharmacy supply fee for initial immunosuppressive drug(s), first month following transplant
- Short description
- Dispens fee immunosupressive
- Pricing indicator
46Priced by carrier (not otherwise classified / individual determination)- Medicare coverage
DSpecial coverage instructions apply- BETOS category
O1EOther drugs- Added
- January 1, 2006
- Last change
- January 1, 2006 – No change
Frequently asked questions
What is HCPCS code Q0510?
Q0510 is a HCPCS Level II code for pharmacy supply fee for initial immunosuppressive drug(s), first month following transplant.
Does Medicare cover Q0510?
The HCPCS file lists coverage code D: Special coverage instructions apply. Coverage and payment also depend on local coverage determinations and the patient’s plan.
Nearby Q codes
- Q0501 – Shower cover for use with electric or electric/pneumatic ventricular assist device, replacement only
- Q0502 – Mobility cart for pneumatic ventricular assist device, replacement only
- Q0503 – Battery for pneumatic ventricular assist device, replacement only, each
- Q0504 – Power adapter for pneumatic ventricular assist device, replacement only, vehicle type
- Q0506 – Battery, lithium-ion, for use with electric or electric/pneumatic ventricular assist device, replacement only
- Q0507 – Miscellaneous supply or accessory for use with an external ventricular assist device
- Q0508 – Miscellaneous supply or accessory for use with an implanted ventricular assist device
- Q0509 – Miscellaneous supply or accessory for use with any implanted ventricular assist device for which payment was not made under medicare part a
- Q0511 – Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period
- Q0512 – Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period
- Q0513 – Pharmacy dispensing fee for inhalation drug(s); per 30 days
- Q0514 – Pharmacy dispensing fee for inhalation drug(s); per 90 days
- Q0515 – Injection, sermorelin acetate, 1 microgram
- Q0516 – Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription oral drug, per 30-days
- Q0517 – Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription oral drug, per 60-days
- Q0518 – Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription oral drug, per 90-days
Source: CMS HCPCS Level II quarterly file, October 2026. Reference only – check payer policy before billing.